Cardiovascular Assessment up to One Year After COVID-19 Vaccine-Associated Myocarditis
- PMID: 37523760
- PMCID: PMC10373639
- DOI: 10.1161/CIRCULATIONAHA.123.064772
Cardiovascular Assessment up to One Year After COVID-19 Vaccine-Associated Myocarditis
Keywords: COVID-19 vaccines; adolescent; echocardiography; magnetic resonance imaging; myocarditis; treatment outcome.
Conflict of interest statement
Figures
References
-
- Kracalik I, Oster ME, Broder KR, Cortese MM, Glover M, Shields K, Creech CB, Romanson B, Novosad S, Soslow J, et al. ; Myocarditis Outcomes After mRNA COVID-19 Vaccination Investigators and the CDC COVID-19 Response Team. Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study. Lancet Child Adolesc Health. 2022;6:788–798. doi: 10.1016/S2352-4642(22)00244-9 - PMC - PubMed
-
- Eichhorn C, Greulich S, Bucciarelli-Ducci C, Sznitman R, Kwong RY, Grän C. Multiparametric cardiovascular magnetic resonance approach in diagnosing, monitoring, and prognostication of myocarditis. JACC Cardiovasc Imaging. 2022;15:1325–1338. doi: 10.1016/j.jcmg.2021.11.017 - PubMed
-
- Schauer J, Buddhe S, Gulhane A, Sagiv E, Studer M, Colyer J, Chikkabyrappa SM, Law Y, Postman MA. Persistent cardiac magnetic resonance imaging findings in a cohort of adolescents with post-coronavirus disease 2019 mRNA vaccine myopericarditis. J Pediatr. 2022;245:233–237. doi: 10.1016/j.jpeds.2022.03.032 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
